Bioactive factors of aloe vera plants
    1.
    发明授权
    Bioactive factors of aloe vera plants 失效
    芦荟植物的生物活性因子

    公开(公告)号:US5902796A

    公开(公告)日:1999-05-11

    申请号:US532060

    申请日:1995-09-22

    CPC分类号: A61K36/886

    摘要: A bioactive Factor produced, separated and isolated from either an aloe vera leaf or a product derived and processed from an aloe leaf, such as raw aloe vera gel, freeze-dried aloe vera gel extract, bulk acetylated mannan and bulk pharmaceutical mannan, utilizing different sizing processes, their processes or preparations, and their uses. The process of sizing can be accomplished by centrifugation, filtration, ultrafiltration, chromatography, dialysis, selective precipitation, pH adjustment, irradiation, homogenizing, or a combination of such processes. Compounding or mixing two or more different bioactive Factors from aloe at various concentration ratios, each Factor with its own specific bioactivity or bioactivities, to obtain a new bioactive Factor having desired optimal additive or synergistic effects.

    摘要翻译: 从芦荟叶中生产,分离和分离的生物活性因子,或者从芦荟叶(如芦荟芦荟凝胶),冷冻干燥的芦荟凝胶提取物,大量乙酰化甘露聚糖和散装药物甘露聚糖衍生和加工的产品,利用不同的 规模化流程,流程或准备工作及其用途。 上浆过程可以通过离心,过滤,超滤,色谱,透析,选择性沉淀,pH调节,照射,均化或这些方法的组合来完成。 将各种浓度比的芦荟混合或混合两种或多种不同的生物活性因子,每种因子具有其自身的特异性生物活性或生物活性,以获得具有所需最佳添加剂或协同效应的新生物活性因子。

    Pharmaceutical compositions comprising Aloe pectins, and methods for their production and use
    2.
    发明申请
    Pharmaceutical compositions comprising Aloe pectins, and methods for their production and use 失效
    包含芦荟胶囊的药物组合物及其生产和使用方法

    公开(公告)号:US20060211653A1

    公开(公告)日:2006-09-21

    申请号:US11437993

    申请日:2006-05-19

    IPC分类号: C08B37/06

    CPC分类号: A61K9/5063 C08B37/0045

    摘要: Pectins having a combination of unexpectedly high molecular weights and low degrees of methylation have been isolated from Aloe vera plants, are superior gel pectins for forming calcium cross-lined gels. Such pectins can be obtained by extracting homogenized Aloe Vera plants or portions thereof. These pectins can be used to prepare pharmaceutical compositions comprising pharmacological agents for application to animals and humans, so as to provide controlled release of the pharmacological agent.

    摘要翻译: 具有意想不到的高分子量和低甲基化度的组合的果胶已经从芦荟植物中分离出来,是用于形成交错排列的凝胶的优异凝胶果胶。 这样的果胶可以通过提取均质的芦荟植物或其部分来获得。 这些果胶可用于制备包含用于施用于动物和人的药理学试剂的药物组合物,以便提供药理学试剂的受控释放。

    Charged particle energy spectrometer
    5.
    发明授权
    Charged particle energy spectrometer 失效
    带电粒子能谱仪

    公开(公告)号:US4593196A

    公开(公告)日:1986-06-03

    申请号:US641203

    申请日:1984-08-16

    申请人: Kenneth Yates

    发明人: Kenneth Yates

    CPC分类号: H01J49/025 H01J49/484

    摘要: A charged particle energy spectrometer, typically an electron spectrometer, comprising an electrostatic dispersive charged particle analyzer, e.g. a substantially hemispherical sector analyzer (1,6), and a detector means comprising a plurality of charged particle detectors (26-28) is described. Fringing fields at the exit of the analyzer are corrected by a fringing field corrector plate (7) containing a plurality of apertures (20, 22, 23) each aligned with one channel of the detector means. Exit beam defining slits (21, 24, 25) in a plate (12) situated in the exit focal plane of the analyzer may optionally be provided. Each aperture (20, 22, 23) is preferably the same size and shape as the single aperture used to achieve optimum correction of the fringing fields in a conventional spectrometer having a single channel detector. One or more position sensitive detectors may be used in place of some or all of the detectors (26-28).

    摘要翻译: 带电粒子能量谱仪,通常是电子分光计,包括静电分散带电粒子分析仪, 描述了一个基本上半球形的扇形分析器(1,6),以及包括多个带电粒子检测器(26-28)的检测器装置。 分析仪出口处的定影场由包含多个孔(20,22,23)的边缘场校正板(7)进行校正,每个孔与检测器装置的一个通道对准。 可以可选地提供位于分析器的出射焦平面中的板(12)中的出射光束限定狭缝(21,24,25)。 每个孔(20,22,23)优选地与用于在具有单通道检测器的常规光谱仪中实现边缘场的最佳校正的单个孔相同的尺寸和形状。 可以使用一个或多个位置敏感检测器代替部分或全部检测器(26-28)。